Clinical Trial Update: Study of TDM-180935 in Atopic Dermatitis Patients [Phase 2]

View source ↗

Summary

Phase 2 study of TDM-180935 in atopic dermatitis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• TDM-180935

Snippet

Sponsor: Technoderma Medicines Inc. | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED